FDA.reportPublic FDA data

Application 208606

Type
ANDA
Sponsor
CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDETABLET;ORAL75MGNoNo
002BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDETABLET;ORAL100MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
71209-052Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-052Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-052Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-052Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-052Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-053Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-053Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-053Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-053Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-053Bupropion HydrochlorideBupropion HydrochlorideCadila Pharmaceuticals LimitedANDACurrent
72241-020Bupropion HydrochlorideBupropion HydrochlorideModavar Pharmaceuticals LLCANDACurrent
72241-021Bupropion HydrochlorideBupropion HydrochlorideModavar Pharmaceuticals LLCANDACurrent